Skip to Main Content

Paper Details

Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
J Neurooncol
3
2021
Author NameAffiliation
Ping ZhuThe University of Texas Health Science Center at Houston, McGovern Medical School
Ping ZhuUTHealth School of Public Health
Yoshua EsquenaziThe University of Texas Health Science Center at Houston, McGovern Medical School
Yoshua EsquenaziCenter for Precision Health, McGovern Medical School, The University of Texas Health Science Center at Houston
Yoshua EsquenaziMemorial Hermann Hospital-TMC
  • 1 - 5

Datasets